Quick answer
Semax is a synthetic heptapeptide based on an ACTH fragment (often written MEHFPGP). Researchers study it for cognition and neuroprotection themes. CoreVials Semax is for laboratory research only, not for human or animal use.
ACTH is a larger hormone. Semax keeps a short CNS-focused fragment design and drops the classic adrenal hormone story in most research descriptions. That is why it shows up in nootropic and neuroprotection literature more than in endocrine textbooks.
Also see Selank and Semax compared and the Semax 10mg protocol page.
What is Semax?
Semax is usually described as an ACTH(4-10) analogue with a Pro-Gly-Pro style extension that improves stability in research write-ups. Sequence shorthand: MEHFPGP.
Labs care about that structure because it is short, synthesizable, and tied to a long Russian research program on cognition and ischemic models.
What do studies look at?
- Learning, attention, and operator-performance style endpoints in older human volunteer reports
- EEG changes around short hypoxic / hyperventilation challenges in published Semax work
- BDNF / trkB expression changes in rodent hippocampus and ischemia models
- Neuroprotection themes under hypoxia or ischemic stress in animal systems
Some human volunteer papers report nootropic-like EEG and performance findings after intranasal Semax. Sample sizes and study designs vary, and Western large-scale RCTs are not the main evidence base.
How to read the evidence
Treat Semax like other investigational neuropeptides: interesting mechanistic and regional clinical literature, not a universal proof of everyday cognitive enhancement. Match claims to the actual paper design.
Research boundary: CoreVials Semax is a research material. It is not approved as a U.S. dietary supplement or drug through this storefront. Confirm lots with COA lookup when documentation is available.
Bottom line
- Semax = synthetic ACTH-fragment analogue (MEHFPGP)
- Research lanes: cognition, EEG/operator studies, neurotrophic signaling, ischemia models
- Evidence quality varies by paper and region
- Laboratory research use only
References
- Kaplan, A.Y., et al. (1996/1999). Synthetic ACTH analogue Semax displays nootropic-like activity in humans. Neuroscience Research Communications. PDF
- Dolotov, O.V., et al. (2006). Semax, an analogue of ACTH(4-10), regulates BDNF and trkB expression in rat hippocampus. Brain Research.
- Ashmarin, I.P., et al. Semax development literature from Russian Institute of Molecular Genetics / pharmacology groups.
